Medicine and Dentistry
Bortezomib
12%
Cell Surface
12%
Congenital Malformation
100%
Endothelial Cell
50%
Hyperactivation
37%
Lymphatic Malformation
100%
Mammalian Target of Rapamycin
25%
Oprozomib
12%
Proteasome
37%
Proteasome Inhibitor
50%
Protein Degradation
25%
Protein Homeostasis
100%
Somatic Mutation
12%
Target Cell
12%
Target Protein
12%
Transgenic Mouse
12%
Treatment Response
100%
Vascular Anomaly
12%
Vascularity
12%
Biochemistry, Genetics and Molecular Biology
Blood Flow
20%
CD31
60%
KRAS
20%
Mammalian Target of Rapamycin
40%
Mouse Model
20%
Proteasome
60%
Proteasome Inhibitor
80%
Protein Catabolism
40%
Protein Homeostasis
100%
Somatic Mutation
20%
Target Cell
20%
Transgenic Mouse
20%
Vascularization
20%
Immunology and Microbiology
Blood Flow
14%
CD31
42%
Cell Surface
14%
Mouse Model
14%
Proteasome
100%
Protein Degradation
28%
Protein Homeostasis
100%
Somatic Mutation
14%
Target Cell
14%
Transgenic Mouse
14%
Vascularization
14%